ClinOne, a Needham, MA-based provider of a technology platform connecting, informing, and empowering patients in global clinical trials, raised $2M in additional funding.
The initial Series A funding round was announced in April and was led by venture capital firm Boulder Ventures with participation by existing investors. In this round, Boulder Ventures and Highpoint Ventures joined to extend the funding. ClinOne also announced the appointment of Katherine Vandebelt and JeanMarie Markham to its Board. Both will contribute their extensive experience and strategic insights to support the growth vision.
The company intends to use the funds to expand operations and its business reach.
ClinOne connects, informs, and empowers patients, care partners, and sites in clinical trials with a single platform for trial awareness, consent management, and patient experience/retention – underpinned with comprehensive data insights tools and standards-based interoperability. Used by more than 80 sponsors, CROs, and site networks in 60 countries, its solutions are proven to reduce risk and simplify processes for therapeutic areas and patient populations including Oncology, Rare Disease, Pediatrics, the Elderly, and CNS.